financetom
Business
financetom
/
Business
/
DoiT Acquires Cloud Cybersecurity Platform CloudWize to Converge Cloud Security and Outcome-Focused Approach to Cloud Intelligence
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DoiT Acquires Cloud Cybersecurity Platform CloudWize to Converge Cloud Security and Outcome-Focused Approach to Cloud Intelligence
Oct 23, 2025 6:55 AM

The acquisition is part of DoiT's $250 million investment into AI-driven CloudOps and FinOps

SANTA CLARA, Calif. & TEL AVIV, Israel--(BUSINESS WIRE)--

DoiT, provider of enterprise-grade FinOps and CloudOps solutions, today announced the acquisition of CloudWize, a multi-cloud security posture and compliance platform. This tech acquisition extends DoiT Cloud Intelligence™ beyond cloud financial management to include intelligent security posture, compliance, and automated guardrails, connecting risk, reliability, and cost into a unified, outcome-driven platform.

CloudWize technology delivers a continuous Security Graph for incident response investigations within Amazon Web Services. Its platform detects misconfigurations, compliance drift, and attack paths, and automates remediation through policy-as-code guardrails. CloudWize’s unique ability to connect security posture findings to cost impact directly aligns with DoiT Cloud Intelligence’s outcome-focused approach.

“Over the last decade, we’ve learned that many FinOps or CloudOps problems actually start as security drift and misconfiguration,” said Vadim Solovey, CEO of DoiT. “We’ve built our platform to catch cost anomalies in real time, but the best problem is the one you never create. CloudWize brings cost-aware, context-driven security to DoiT Cloud Intelligence, helping customers prevent the misconfigurations that become waste, outages, and risk. It turns posture into guardrails—and guardrails into lower spend.”

With this acquisition, DoiT strengthens its leadership position in the evolving FinOps 3.0 landscape, bridging the gap between FinOps, SecOps, and DevOps. The combined capabilities will allow organizations to prioritize risks by business impact, automate remediation through DoiT CloudFlow, and accelerate compliance without waste, helping teams act with confidence and speed.

“From the beginning, CloudWize’s mission was to simplify and secure the multi-cloud journey,” said Chen Goldberg, CEO and founder of CloudWize. “Joining DoiT allows us to scale that vision globally, helping customers turn security and compliance into strategic advantages that drive both resilience and efficiency.”

The acquisition of CloudWize technology follows DoiT’s recent integrations of PerfectScale and LiveDiagrams, continuing the company’s expansion into intelligent automation across Kubernetes optimization, architecture visualization, and now multi-cloud security posture.

To DoiT, the addition of CloudWize technology marks another major milestone in building an intent-aware platform for CloudOps and FinOps, where every decision from spend to security is informed by context and automated for action.

About DoiT

DoiT is a global leader with its DoiT Cloud Intelligence™ platform, providing intent-aware FinOps and CloudOps solutions that help businesses maximize the impact of their cloud investments. With deep expertise in AWS, Google Cloud, and Azure, DoiT Cloud Intelligence empowers organizations to connect every dollar spent to the goals of each workload, uncover the root causes of inefficiency, and close the loop with engineering teams to drive real optimization. To learn more, visit doit.com.

About CloudWize by DoiT

CloudWize by DoiT is a multi-cloud security posture and compliance platform that provides continuous protection across AWS, Google Cloud, and Azure. With its graph-based architecture, CloudWize delivers full visibility into cloud environments, detects misconfigurations and compliance drift, and automates remediation through policy-as-code. By connecting security and cost, CloudWize enables SecOps, DevOps, and FinOps teams to align on shared priorities that reduce both risk and waste. Learn more at cloudwize.io.

Source: DoiT

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers
Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers
Dec 16, 2024
08:04 AM EST, 12/16/2024 (MT Newswires) -- Procter & Gamble ( PG ) promised a group of shareholders it would disclose more details on its audit practices for wood pulp suppliers, Reuters reported Monday, citing the investors. Certain shareholders have been pushing the company to source forest products more sustainably, the report said. The investors and P&G are next expected...
Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million
Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million
Dec 16, 2024
08:09 AM EST, 12/16/2024 (MT Newswires) -- Phillips 66 (PSX) said Monday it agreed to sell DCP GCX Pipeline, which holds a 25% non-operated stake in the Gulf Coast Express Pipeline, to an ArcLight Capital Partners affiliate for pre-tax proceeds of $865 million in cash, subject to adjustments. The energy provider said the sale price represents a 10.6x multiple of...
Whitecap Resources Says Q4, Full-Year Production to Beat Guidance
Whitecap Resources Says Q4, Full-Year Production to Beat Guidance
Dec 16, 2024
08:05 AM EST, 12/16/2024 (MT Newswires) -- Whitecap Resources ( SPGYF ) on Monday said fourth-quarter production is now forecast to average 175,500 boe/d (65% liquids), above its previous guidance of 170,000 boe/d. Full-year production is expected to average 174,000 boe/d, 5% above Whitecap's original guidance of 162,000 - 168,000 boe/d. The company's annual production per share growth in 2024...
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Dec 16, 2024
08:05 AM EST, 12/16/2024 (MT Newswires) -- Soligenix ( SNGX ) said Monday it has begun patient enrollment for its phase 3 study of its experimental therapy, HyBryte, to treat cutaneous T-cell lymphoma or CTCL. The company said the study builds on previous phase 3 results and additional supportive research. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved